COVID-19 mortality: are comorbidities, socio-economic status and ethnicity more important than cancer?

Ann Transl Med. 2022 Dec;10(24):1302. doi: 10.21037/atm-22-5592.

Authors

Lauren Seknazi¹, Mathieu Jamelot¹, Florence Canouï-Poitrine^{2

3}, Joseph Gligorov^{1

4}, Marc-Antoine Benderra^{1

2

3}

Affiliations

¹ Department of Medical Oncology, Institut Universitaire de Cancérologie, Sorbonne University, AP-HP, Tenon Hospital, Paris, France.
² Université Paris-Est Créteil, INSERM, IMRB, Créteil, France.
³ AP-HP, Henri-Mondor Hospital, Public Health Department & Clinical Research Unit (URC Mondor), Créteil, France.
⁴ INSERM U938, CRSA, Institut Universitaire de Cancérologie, AP-HP Sorbonne Université, Paris, France.

No abstract available

Keywords: Coronavirus disease 2019 (COVID-19); comorbidities; ethnicity.

Publication types

Editorial
Comment